Danaher Corporation

DHR · Healthcare

About Danaher Corporation

Danaher Corporation (DHR) has been publicly traded since 1978, making it a 48-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in Washington, United States and employs approximately 58,000 people. With a market capitalization of $132 billion, DHR is a large established company.

Key Statistics

Current Price
$186.79
Market Cap
$132.09B
52-Week High
$242.80
52-Week Low
$171.00
Sector
Healthcare
Industry
Diagnostics & Research

$1,000 Invested

1 Year
$921
+-8%
3 Years
$878
+-12%
5 Years
$996
+-0%
10 Years
$5,037
+404%
Since IPO
$4,212,564
+421156%

Monthly Returns Heatmap

Annual Returns

Avg Return
+22.18%
Best Year
1983 (+80.00%)
Worst Year
2008 (-35.37%)
Positive Years
36/48
Year Return Start End
2026 -18.40% $228.92 $186.79
2025 +0.35% $228.12 $228.92
2024 -0.35% $228.91 $228.12
2023 -1.24% $231.78 $228.91
2022 -19.02% $286.22 $231.78
2021 +48.57% $192.66 $286.22
2020 +45.34% $132.56 $192.66
2019 +49.55% $88.64 $132.56
2018 +11.80% $79.28 $88.64
2017 +20.01% $66.06 $79.28
2016 +73.07% $38.17 $66.06
2015 +9.04% $35.00 $38.17
2014 +11.59% $31.37 $35.00
2013 +38.31% $22.68 $31.37
2012 +19.06% $19.05 $22.68
2011 -0.09% $19.07 $19.05
2010 +25.69% $15.17 $19.07
2009 +33.11% $11.40 $15.17
2008 -35.37% $17.63 $11.40
2007 +21.29% $14.54 $17.63
2006 +30.02% $11.18 $14.54
2005 -2.71% $11.49 $11.18
2004 +25.29% $9.17 $11.49
2003 +39.81% $6.56 $9.17
2002 +9.09% $6.01 $6.56
2001 -11.67% $6.81 $6.01
2000 +41.90% $4.80 $6.81
1999 -11.06% $5.40 $4.80
1998 +72.31% $3.13 $5.40
1997 +35.64% $2.31 $3.13
1996 +47.21% $1.57 $2.31
1995 +21.85% $1.29 $1.57
1994 +37.46% $0.94 $1.29
1993 +47.18% $0.64 $0.94
1992 +28.40% $0.50 $0.64
1991 +26.56% $0.39 $0.50
1990 +4.92% $0.37 $0.39
1989 +7.96% $0.35 $0.37
1988 +66.18% $0.21 $0.35
1987 +37.37% $0.15 $0.21
1986 +57.14% $0.10 $0.15
1985 +12.50% $0.09 $0.10
1984 +55.56% $0.06 $0.09
1983 +80.00% $0.03 $0.06
1982 -28.57% $0.04 $0.03
1981 -17.65% $0.05 $0.04
1980 -8.11% $0.06 $0.05
1979 +27.59% $0.04 $0.06

Valuation

DHR currently trades at a trailing P/E ratio of 37.2, which is considered high relative to the broader market. The forward P/E of 20.6 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 2.5. The price-to-sales ratio is 5.4.

Dividends

Danaher Corporation pays a dividend to shareholders with a current yield of 0.85%. This translates to $1.60 per share annually. The payout ratio of 25% indicates sustainable dividend coverage.

Risk & Volatility

DHR has a beta of 0.96, indicating it is similarly volatile to the overall market. The stock's 52-week range is $171.00 to $242.80, and it currently trades in the lower half of its 52-week range.

Analyst Ratings

Based on 22 analyst opinions, DHR has a consensus "strong_buy" rating. The average price target of $264.91 suggests 41.4% upside from current levels.

Frequently Asked Questions

What does Danaher Corporation do?

Danaher Corporation is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Washington, United States.

What sector is DHR in?

DHR operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

When did DHR go public?

Danaher Corporation went public in 1978, making it a 48-year-old public company as of 2026.

How much would $1,000 invested in DHR 5 years ago be worth today?

A $1,000 investment in DHR five years ago would be worth approximately $996 today, representing a -0.5% return.

Does DHR pay dividends?

Yes, Danaher Corporation pays a dividend with a current yield of 0.85%, which is $1.6 per share annually.

What is DHR's market cap?

Danaher Corporation has a market capitalization of $132 billion, classifying it as a large-cap company.

What is DHR's P/E ratio?

DHR has a trailing P/E ratio of 37.2 and a forward P/E of 20.6, which measures how much investors are paying per dollar of earnings.

Is DHR a buy, hold, or sell?

Based on 22 opinions, DHR has a consensus "strong_buy" rating. The average price target is $264.91.

Last updated: 3/14/2026